Market Tracker

12/09 5:16pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

17.40
Delayed Data
As of Dec 09
 +0.41 / +2.41%
Today’s Change
15.92
Today|||52-Week Range
44.49
-59.68%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close16.99
Today’s open17.00
Day’s range16.99 - 17.62
Volume954,547
Average volume (3 months)1,843,241
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+58.33%
Earnings growth (this year)-37.50%
Earnings growth (next 5 years)+3.80%
Revenue growth (last year)+4.25%
P/E ratio13.7
Price/Sales2.98
Price/Book1.57

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...+0.10+0.33%
VIVOMeridian Bioscience ...0.000.00%
QDELQuidel Corp+0.31+1.36%
--Quidel Corp+0.77+3.81%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$753.8M
Annual profit (last year)$125.3M
Net profit margin16.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts